Can incretin-based therapy and SGLT-2 inhibitors may be useful in the treatment of diabetes type 1?

被引：0
|
作者：
Rozanska, Paulina [1 ]
Wierusz-Wysocka, Bogna [1 ]
Zozulinska-Ziolkiewicz, Dorota [1 ]
机构：
[1] Uniwersytetu Med Karola Marcinkowskiego Poznaniu, Katedra & Klin Chorob Wewnetrznych & Diabetol, Poznan, Poland
来源：
CLINICAL DIABETOLOGY | 2015年 / 4卷 / 04期
关键词：
diabetes mellitus type 1; incretin-based therapy; SGLT-2; inhibitors;
D O I：
10.5603/DK.2015.0015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
It is known, that insulin therapy is essential in the treatment of type 1 diabetes. Insulin therapy has been related with some side effects such as hypoglycemia and weight gain, strongly connected with insulin resistance. Therefore the metformin is used sometimes as additive therapy In patients with type 1 diabetes. Recently, glukagon-like peptide 1 (GLP-1) analogs, dipeptydyl peptidase 4 (DPP-4) inhibitors and sodium glucose co-transporter 2 inhibitors (SGLT-2) has been raported to be beneficial for the glycemic control in type 1 diabetic.
引用
收藏
页码：147 / 151
页数：5
相关论文
共 50 条
  • [1] Incretin-Based Therapy in Type 2 Diabetes Treatment with Comedication
    Kern, W.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (01): : 29 - 33
  • [2] Combination therapy of SGLT2 inhibitors with incretin-based therapies for the treatment of type 2 diabetes mellitus: Effects and mechanisms of action
    Schernthaner-Reiter, Marie Helene
    Schernthaner, Guntram
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (03) : 281 - 296
  • [3] INCRETIN-BASED THERAPY AND TYPE 2 DIABETES
    Hare, Kristine J.
    Knop, Filip K.
    VITAMINS AND HORMONES: INCRETINS AND INSULIN SECRETION, 2010, 84 : 389 - 413
  • [4] SGLT-2 inhibitors as adjunctive to insulin therapy in type 1 diabetes
    Maj-Podsiadlo, Anna
    Cichocka, Edyta
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2020, 9 (03): : 189 - 192
  • [5] Which incretin-based therapy for type 2 diabetes?
    Scheen, Andre J.
    LANCET, 2014, 384 (9951): : 1325 - 1327
  • [6] Incretin-Based Therapy of Type 2 Diabetes Mellitus
    Knop, Filip K.
    Vilsboll, Tina
    Holst, Jens J.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2009, 10 (01) : 46 - 55
  • [7] Treatment of type 2 diabetes with incretin-based therapies
    Madsbad, Sten
    LANCET, 2009, 373 (9662): : 438 - 439
  • [8] Individualised incretin-based treatment for type 2 diabetes
    Nauck, Michael A.
    Meier, Juris J.
    LANCET, 2010, 376 (9739): : 393 - 394
  • [9] Incretin-Based Therapy: a Complementary Approach in the Treatment of Patients with Type 1 Diabetes?
    Gallwitz, B.
    Kienhoefer, J.
    DIABETOLOGIE UND STOFFWECHSEL, 2015, 10 (02) : 85 - 90
  • [10] Positioning SGLT2 Inhibitors/Incretin-Based Therapies in the Treatment Algorithm
    Wilding, John P. H.
    Rajeev, Surya Panicker
    DeFronzo, Ralph A.
    DIABETES CARE, 2016, 39 : S154 - S164
12345